# OnCo record inge-van-der-sluis (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/inge-van-der-sluis/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "inge-van-der-sluis" ;
  schema:name "Inge M. van der Sluis"@en ;
  schema:description "Dutch paediatric oncologist who led the study showing that adding one course of blinatumomab to chemotherapy sharply improves survival for babies with KMT2A-rearranged leukaemia."@en ;
  schema:url <https://onco.cc/people/inge-van-der-sluis/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "paediatric", "leukaemia", "immunotherapy", "trialist" ;
  schema:jobTitle "Paediatric oncologist, Princess Máxima Center for Pediatric Oncology" ;
  schema:sameAs <https://orcid.org/0000-0002-5822-7668> ;
  onco:cancers <https://onco.cc/cancers/all-infant/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/childhood-cancers/> ;
  onco:institutions <https://onco.cc/institutions/princess-maxima/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-blinatumomab-infant-all-van-der-sluis-nejm-2023/> ;
  schema:affiliation <https://onco.cc/institutions/princess-maxima/> .